Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Evidence outside the box: Minimally invasive treatment for anal fistula

Chua KHL., Lee DJK.

Narrative Review on Autoimmune Research, published in World J Gastrointest Surg (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
World J Gastrointest Surg (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41357640
PMCID
PMC12679015
DOI
10.4240/wjgs.v17.i11.111285

Abstract (original English)

Management of the complex anal fistula represents a perennial challenge to surgeons. Conventional approaches often upset the balance between recurrence prevention and continence preservation with their high failure rates and significant associated morbidity. The emergence of minimally invasive treatment in recent years, however, offers a promising paradigm shift. Regenerative solutions like autologous stem cell therapy or fistula plugs with extracellular and synthetic matrices represent new frontiers in anal fistula treatment, harnessing physiological regenerative capacities and avoiding the traditional postoperative burden of open wounds, drains, or setons in situ . Together with novel techniques like fistula laser closure, video-assisted fistula treatment, or over-the-scope clip burgeoning over the last decade, these state-of-the-art approaches have been touted for their total sphincter-sparing nature, preserving functional outcomes and quality of life. Despite gaining much scientific and clinical momentum, do these newer modalities live up to their promise? This review aims to critically appraise the latest evidence surrounding minimally invasive approaches, providing up-to-date insights into the constantly evolving landscape of anal fistula management. Further long-term and comparative studies will nevertheless be needed to supplement the significantly heterogenous, retrosp

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research